morgan stanley news - Search News

Morgan Stanley promotes 173 employees to managing director

Business Insider · 1h

Morgan Stanley welcomed a new class of leaders this week. See all 173 managing director names here.

These 173 leaders will help steer the firm as Wall Street readies for a potential flood of dealmaking, from M&A to IPOs.

Morgan Stanley promotes 173 employees to managing directors, source says

Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase from 2024, a source close to the matter told Reuters on Wednesday.

Bloomberg L.P. · 1d

Morgan Stanley to Hire More Asia Wealth Relationship Managers

Morgan Stanley’s Asia wealth chief is looking to boost the number of staff dealing with its richest customers as the US lender pushes ahead with its regional expansion.

Business Insider · 2d

Morgan Stanley promotes 173 employees to managing director, up 12% as dealmaking rebounds

The bulk of Morgan Stanley's new managing directors, or 46%, work for the investment bank.

ViewusGlobal on MSN · 1d

173 Morgan Stanley Employees Elevated to Managing Director—Here’s What’s Driving the Surge

Morgan Stanley promotes 173 employees to managing director, showing optimism in banking amid strong earnings and potential regulatory changes.

Morgan Stanley, Gilead Sciences

Seeking Alpha on MSN · 5h

Gilead upgraded by Morgan Stanley on lenacapavir potential

Morgan Stanley has upgraded Gilead Sciences (NASDAQ:GILD) to overweight from equal weight, citing the company's HIV drug lenacapavir. The investment bank said it was "leaning into the bull case," seeing "the potential for upward estimate revisions on lenacapavir for PrEP and further multiple expansion as the company makes progress with its

Business Insider · 13h

Gilead upgraded to Overweight from Equal Weight at Morgan Stanley

Morgan Stanley upgraded Gilead (GILD) to Overweight from Equal Weight with a price target of $113, up from $87. The firm sees the potential for

Investing.com on MSN · 7h

Morgan Stanley upgrades Gilead on HIV treatment growth

Morgan Stanley upgraded Gilead Sciences Inc (NASDAQ:GILD) to "overweight" from "equal weight," raising its price target to $113 from $87 on HIV prevention drug Lenacapavir (PrEP) and next-gen HIV treatments.

2h

Morgan Stanley stock underperforms Friday when compared to competitors

Morgan Stanley closed $12.79 short of its 52-week high ($136.24), which the company achieved on November 25th.

Dive Deposits: Morgan Stanley’s MD promotions don’t set records, they follow the herd

While Citi, BofA and Goldman touted their biggest cohorts of managing directors in years, Morgan Stanley elevated greater ...

1d

$1.2 Billion Morgan Stanley Team Thinks Dividend Investing Could Be Myopic

Robert Chen and his team like strategies like direct indexing because they systematically tax loss harvest throughout the ...

8h

Alcohol-Free Guinness Won’t Shield Diageo, Says Morgan Stanley

The popularity of alcohol-free Guinness won’t protect the shares of its owner Diageo Plc from the growing trend toward health ...

1d

Morgan Stanley Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

JP Morgan analyst Kian Abouhossein maintained a Neutral rating and boosted the price target from $100 to $104 on Dec. 6, 2024 ...

2d

Jim Cramer Predicts Palantir Buying Surge Tonight After Morgan Stanley's Underweight Rating: 'Unless Another Analyst Starts With A Sell...'

Morgan Stanley initiated coverage of Palantir Technologies Inc. (NYSE:PLTR) with an underweight rating and $60 price target ...

1d

The tough-love advice Morgan Stanley CIO Mike Wilson gives to his new hires to prepare for their career in banking

"Everybody knows you made a mistake. How are you going to deal with that?" ...

11h

Morgan Stanley's Mike Wilson On Taking Risks – 'The Real Money Is Made With Contrarian Views'

Mike Wilson, Morgan Stanley's chief investment officer, has some advice for anyone looking to advance in their career: Take ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results